A research consortium focusing on the development of highly resistant cancer cell lines for testing new antiviral treatments. By understanding how cancer cells evolve resistance, CREP aims to design more robust therapies and preemptively address potential treatment failures. It involves developing open-source tools and sharing research findings rapidly to advance cancer therapies. It takes a preemptive effort in the understanding of Cancer and its resistant properties for a more rapid adaptive method of treatment.